Form D · Biotechnology
Layka Bio Inc
Newton Highlands, MA · CIK 0002148283
Offering snapshot reported Aug 7, 2026 · SEC filing
- Reported sold
- $300K Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 27, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 7, 2026 | Initial | $300,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-593433
Convertible promissory notes and securities issuable upon conversion
Source: Form D, filed Aug 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Kron | Promoter |
| Ante S Lundberg | Director, Executive, Promoter |
| Matthew Meyerson | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
19 Terrace Ave
Newton Highlands, MA, 02461
Phone: 6173199180
Newton Highlands, MA, 02461
Phone: 6173199180